The expression of HSP47 is confirmed to be regulated by the profibrogenic cytokine TGF-β, and further investigations should be performed to validate this potential prognosis biomarker for SSc patients and important therapeutic target for fibrosis disorders. This evidence concerns the gene SERPINH1 and systemic sclerosis.